ADENOSINE RECEPTOR CONTEXT-SPECIFIC BIASED AGONISM TO TREAT ISCHAEMIC HEART DISEASE

Grant number: 1147291 | Funding period: 2018 - 2020

Completed

Abstract

Heart attacks and secondary heart failure remain significant health burdens. Stimulation of adenosine receptors located on heart cells confers powerful cardiac protection, improving acute and longer-term heart function subsequent to a heart attack but avoiding the usual unwanted effects from this approach. We aim to better understand the mechanism of action of potential adenosine receptor therapeutics and establish the clinical potential of these compounds using animal models of heart failure.

Related publications (1)

Positive allosteric mechanisms of adenosine A(1) receptor-mediated analgesia

Christopher J Draper-Joyce, Rebecca Bhola, Jinan Wang, Apurba Bhattarai, Anh TN Nguyen, India Cowie-Kent, Kelly O'Sullivan, Ling Yeong Chia, Hariprasad Venugopal, Celine Valant, David M Thal, Denise Wootten, Nicolas Panel, Jens Carlsson, Macdonald J Christie, Paul J White, Peter Scammells, Lauren T May, Patrick M Sexton, Radostin Danev

2021-09-08

The adenosine A1 receptor (A1R) is a promising therapeutic target for non-opioid analgesic agents to treat neuropathic pain1,2. Ho..

University of Melbourne Researchers

Andrew Kompa Medicine - St Vincent's Hospital